Literature DB >> 23111628

Synthesis and structural characterization of soluble neuromelanin analogs provides important clues to its biosynthesis.

Emanuele Ferrari1, Mireille Engelen, Enrico Monzani, Michela Sturini, Stefania Girotto, Luigi Bubacco, Luigi Zecca, Luigi Casella.   

Abstract

Elucidating the structure and biosynthesis of neuromelanin (NM) would be an important step towards understanding its putative role in the pathogenesis of Parkinson's disease. A useful complement to studies aimed at unraveling the origin and properties of this essentially insoluble natural substance is the preparation of synthetic derivatives that resemble NM. With this aim in mind, water-soluble conjugates between dopamine-derived melanin and bovine serum albumin (BSA) were synthesized. Melanin-BSA adducts were prepared with both eumelanic oligomers obtained through the oxidative polymerization of dopamine and pheomelanic oligomers obtained under the same conditions from dopamine and cysteine. Iron ions were added during the synthesis to understand the interaction between the pigment and this metal ion, as the NM in neurons in several human brain regions contains significant amounts of iron. The structures of the conjugates were analyzed by (1)H NMR spectroscopy and controlled proteolysis/MS experiments. The binding of iron(III) ions was evaluated by ICP analysis and EPR spectroscopy. The EPR signal from bound iron(III) indicated high-spin octahedral sites and, as also seen for NM, the signal is coupled to a signal from a radical associated with the melanic components of the conjugates. However, the intensity of the EPR signal from iron suggested a reduced fraction of the total iron, indicating that most of the iron is strongly coupled in clusters within the matrix. The amount of paramagnetic, mononuclear iron(III) was greater in the pheomelanin-BSA conjugates, suggesting that iron clustering is reduced in the sulfur-containing pigment. Thus, the melanin-BSA conjugates appear to be good models for the natural pigment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23111628     DOI: 10.1007/s00775-012-0951-7

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  47 in total

Review 1.  Amyloid beta and neuromelanin--toxic or protective molecules? The cellular context makes the difference.

Authors:  K S J Rao; M L Hegde; S Anitha; M Musicco; F A Zucca; N J Turro; L Zecca
Journal:  Prog Neurobiol       Date:  2006-05-08       Impact factor: 11.685

Review 2.  The physical and chemical properties of eumelanin.

Authors:  Paul Meredith; Tadeusz Sarna
Journal:  Pigment Cell Res       Date:  2006-12

3.  Binding of iron to neuromelanin of human substantia nigra and synthetic melanin: an electron paramagnetic resonance spectroscopy study.

Authors:  T Shima; T Sarna; H M Swartz; A Stroppolo; R Gerbasi; L Zecca
Journal:  Free Radic Biol Med       Date:  1997       Impact factor: 7.376

4.  EPR investigations of the iron domain in neuromelanin.

Authors:  S Aime; B Bergamasco; D Biglino; G Digilio; M Fasano; E Giamello; L Lopiano
Journal:  Biochim Biophys Acta       Date:  1997-07-10

5.  Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct.

Authors:  K A Conway; J C Rochet; R M Bieganski; P T Lansbury
Journal:  Science       Date:  2001-11-09       Impact factor: 47.728

6.  Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease.

Authors:  Luigi Zecca; Luigi Casella; Alberto Albertini; Chiara Bellei; Fabio A Zucca; Mireille Engelen; Andrzej Zadlo; Grzegorz Szewczyk; Mariusz Zareba; Tadeusz Sarna
Journal:  J Neurochem       Date:  2008-07-04       Impact factor: 5.372

7.  Rate of cell death in parkinsonism indicates active neuropathological process.

Authors:  P L McGeer; S Itagaki; H Akiyama; E G McGeer
Journal:  Ann Neurol       Date:  1988-10       Impact factor: 10.422

Review 8.  The neuromelanin of human substantia nigra and its interaction with metals.

Authors:  L Zecca; D Tampellini; A Gatti; R Crippa; M Eisner; D Sulzer; S Ito; R Fariello; M Gallorini
Journal:  J Neural Transm (Vienna)       Date:  2002-05       Impact factor: 3.575

9.  Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease.

Authors:  E Hirsch; A M Graybiel; Y A Agid
Journal:  Nature       Date:  1988-07-28       Impact factor: 49.962

10.  Spin concentration measurements of high-spin (g' = 4.3) rhombic iron(III) ions in biological samples: theory and application.

Authors:  Fadi Bou-Abdallah; N Dennis Chasteen
Journal:  J Biol Inorg Chem       Date:  2007-10-12       Impact factor: 3.358

View more
  8 in total

Review 1.  Neuromelanin of the human substantia nigra: an update.

Authors:  Fabio A Zucca; Emy Basso; Francesca A Cupaioli; Emanuele Ferrari; David Sulzer; Luigi Casella; Luigi Zecca
Journal:  Neurotox Res       Date:  2013-10-24       Impact factor: 3.911

2.  A reappraisal of Fe(III) adsorption by melanin.

Authors:  Rhiannon Lee Schroeder; Jacobus Petrus Gerber
Journal:  J Neural Transm (Vienna)       Date:  2014-05-21       Impact factor: 3.575

Review 3.  Neuromelanin in Parkinson's Disease: from Fenton Reaction to Calcium Signaling.

Authors:  Rainer Knörle
Journal:  Neurotox Res       Date:  2017-09-06       Impact factor: 3.911

4.  Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease.

Authors:  Fabio A Zucca; Renzo Vanna; Francesca A Cupaioli; Chiara Bellei; Antonella De Palma; Dario Di Silvestre; Pierluigi Mauri; Sara Grassi; Alessandro Prinetti; Luigi Casella; David Sulzer; Luigi Zecca
Journal:  NPJ Parkinsons Dis       Date:  2018-06-05

Review 5.  Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease.

Authors:  Fabio A Zucca; Juan Segura-Aguilar; Emanuele Ferrari; Patricia Muñoz; Irmgard Paris; David Sulzer; Tadeusz Sarna; Luigi Casella; Luigi Zecca
Journal:  Prog Neurobiol       Date:  2015-10-09       Impact factor: 11.685

6.  Cell specific quantitative iron mapping on brain slices by immuno-µPIXE in healthy elderly and Parkinson's disease.

Authors:  T Arendt; M Morawski; I Friedrich; K Reimann; S Jankuhn; E Kirilina; J Stieler; M Sonntag; J Meijer; N Weiskopf; T Reinert
Journal:  Acta Neuropathol Commun       Date:  2021-03-22       Impact factor: 7.801

Review 7.  Interaction of Neuromelanin with Xenobiotics and Consequences for Neurodegeneration; Promising Experimental Models.

Authors:  Andrea Capucciati; Fabio A Zucca; Enrico Monzani; Luigi Zecca; Luigi Casella; Tim Hofer
Journal:  Antioxidants (Basel)       Date:  2021-05-21

8.  Age-associated insolubility of parkin in human midbrain is linked to redox balance and sequestration of reactive dopamine metabolites.

Authors:  Jacqueline M Tokarew; Daniel N El-Kodsi; Nathalie A Lengacher; Travis K Fehr; Angela P Nguyen; Bojan Shutinoski; Brian O'Nuallain; Ming Jin; Jasmine M Khan; Andy C H Ng; Juan Li; Qiubo Jiang; Mei Zhang; Liqun Wang; Rajib Sengupta; Kathryn R Barber; An Tran; Doo Soon Im; Steve Callaghan; David S Park; Stephanie Zandee; Xiajun Dong; Clemens R Scherzer; Alexandre Prat; Eve C Tsai; Masashi Takanashi; Nobutaka Hattori; Jennifer A Chan; Luigi Zecca; Andrew B West; Arne Holmgren; Lawrence Puente; Gary S Shaw; Gergely Toth; John M Woulfe; Peggy Taylor; Julianna J Tomlinson; Michael G Schlossmacher
Journal:  Acta Neuropathol       Date:  2021-03-10       Impact factor: 17.088

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.